ResMed | RMD - Operating Profit


ResMed reported $499.81M in Operating Profit for its fiscal quarter ending in March of 2026.





Operating Profit Change Date
Ansell USD 146.5M 87.85M Dec/2025
Avita Medical AUD -10.41M 742K Dec/2025
Cochlear AUD 261.1M 135.55M Dec/2025
CSL USD 2.64B 1.97B Dec/2025
Fisher & Paykel Healthcare NZD 368.8M 70.6M Jun/2026
Healius AUD -22.6M 47.5M Dec/2024
Integral Diagnostics AUD 19.28M 73.95M Jun/2024
Mayne Pharma AUD -3.3M 15.67M Jun/2024
Nanosonics AUD 9.12M 3.82M Dec/2025
Polynovo AUD 2.06M 1.18M Dec/2025
Ramsay Health Care AUD 541.1M 3.9M Dec/2025
Regis Healthcare AUD 24.67M 11.91M Dec/2025
ResMed USD 499.81M 490K Mar/2026
Sigma Healthcare AUD 809K 13.76M Dec/2024
Sonic Healthcare AUD 435.76M 193.66M Dec/2024
Telix Pharmaceuticals AUD 46.36M 38.32M Jun/2026